期刊文献+

血清清蛋白影响维持性血液透析老年患者并发症的发生

The Effect of Serum Albumin Level on Complications in Elder Hemodialysis Patients
下载PDF
导出
摘要 目的探讨血清清蛋白浓度对维持性血液透析老年患者并发症的影响。方法选取2005年1月~2006年12月我院维持性血液透析病人47例(年龄>65岁),根据血清清蛋白浓度分为2组,A组病人血清清蛋白<35g/L,B组血清清蛋白≥35g/L,观察病人病程中有无贫血、严重感染、心血管并发症及病死率。结果A组病人贫血及感染发生率显著高于B组(P<0.01),心血管并发症发生率高于B组,但未达到显著性差异(P>0.05),病死率明显高于B组(P<0.05)。结论在维持性血液透析的老年患者中,低清蛋白血症增加贫血、感染及心血管并发症的发生率,并增加患者的病死率。 Objective To investigate the impact of serum albumin level on complications in elder patients on maintenance hemodialysis. Methods A total of 47 patients( Age 〉 65Y) on maintenance hemodialysis at our hospital from Jan 2005 to Oct 2006 was selected. All subjects were divided into two groups according to serum albumin level:group A (ALB 〈 35g/L) ,group B (ALB ≥35g/L). Anemia, severe infections, cardiovascular diseases and mortality were considered as main complications. Results The incidence of anemia and severe infections were significant higher in group A than in group B (P 〈 0.01 ) ; The incidence of cardiovascular diseases was higher in group A than in group B,but there was no significant differences(P 〉 0. 05) ;and mortality was higher in group A than in group B(P 〈 0. 05 ). Conclusion In elder MHD patients, hypoalbuminemia could raise the incidence of anemia, severe infections, cardiovascular diseases and death.
出处 《医学研究杂志》 2008年第11期83-85,共3页 Journal of Medical Research
关键词 维持性血液透析 老年患者 血清清蛋白 并发症 Maintenance hemodialysis Elder patients Serum albumin Complications
  • 相关文献

参考文献9

二级参考文献21

  • 1唐琦,汪关煜,钱莹,朱萍,沈平雁.肾性贫血时静脉与口服铁剂的疗效比较[J].中国血液净化,2004,3(8):431-434. 被引量:38
  • 2Sarnak MJ,Jaber BL.Pulmonary infections mortality among patients with end-stage renal disease[J].Chest,2001,120(6) :1883-1887.
  • 3Levy J,Morgan J,Brown E,et al.Oxford handbook of dialysis[M].Oxford:Oxford University Press,2001.487-499.
  • 4Nassar GM,Ayus JC.Infectious complications of the hemodialysis access[J].Kidney Int,2001,60(1):1-13.
  • 5Tokars JI,Light Panderson J.A prospective study of vascular access infections at seven outpatient hemodialysis centers [J].Am J Kidney Dis,2001,37(6):1232-1240.
  • 6Hans MG.Hepatitis B virus infection in hemodialysis patients[J].Semin Nephrol,2002,22(4):340-350.
  • 7Bailie GR,Johnson CA,Mason NA.Parenteral iron use in the management of anemia in end-stage renal disease patients.Am J Kid Dis,2000,35:1.
  • 8Macdougall IC,Tucker B,Thompson J,et al.A randomized controlled study of iron supplementation in patients treated with erythropoietin.Kid Iht,1996,50:1694.
  • 9National Kidney Foundation.K/DOQI Clinical Practice Guidelines for.Anemia of Chronic Kidney Disease,2000,Am J Kidney Dis,37:S182-S238,2001,(suppl 1).
  • 10Agarwal R,Davis JL,Hamburger RJ.A trial of two irondextran infusion regiments in chronic hemodialysis patients.Clin Nephrol,2000,54:105.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部